IP Library Granted Patent US 8,871,806
Granted Patent B2
US 8,871,806 · App. 13/490,213 · Granted Oct 28, 2014

Methods for preventing flea allergy dermatitis in companion animals

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,871,806
App. No.
13/490,213
Granted
Oct 28, 2014
Kind
B2
Abstract

Methods for reducing the incidence of flea allergy dermatitis (FAD) in a companion animal are disclosed, the methods directed to inhibiting blood feeding by ectoparasites on a companion animal. The methods of the present invention involve administering a pesticide composition comprising cyphenothrin to a companion animal, specifically dogs and cats, in doses and proportions which are parasiticidally effective against a variety of ectoparasites, and in formulations which are convenient for topical application to the animal's skin, preferably localized over a small surface area. Such methods are useful in preventing and/or reducing the incidence of flea allergy dermatitis.

Claims (50)

1. A method for reducing the incidence of flea allergy dermatitis in a companion animal by reducing blood feeding by ectoparasites on the companion animal by at least 80%, the method comprising: administering a composition comprising up to about 50% (w/w) cyphenothrin and about 50% to about 85% (w/w) organic solvent, wherein the composition is administered in a volume sufficient to deliver a dosage of cyphenothrin ranging from about 0.1 mg/kg to about 40 mg/kg of animal weight.

2. The method of claim 1 , wherein composition is a spot-on composition.

3. The method of claim 2 , wherein the method further comprises administering a localized cutaneous application of the spot-on composition between the shoulders of the companion animal.

4. The method of claim 1 , wherein blood feeding by ectoparasites is reduced by at least 90%.

5. The method of claim 1 , wherein the ectoparasite is a flea.

6. The method of claim 5 , wherein the flea is Ctenocephalides felis.

7. The method of claim 1 , wherein the composition comprises between about 20% to about 30% (w/w) cyphenothrin.

8. The method of claim 1 , wherein the composition is administered as a one-time treatment.

9. The method of claim 1 , wherein the composition is administered once every five weeks.

10. The method of claim 1 , wherein the composition is administered once every six weeks.

11. The method of claim 1 , wherein the companion animal is a dog.

12. The method of claim 1 , wherein the composition further comprises about 1% to about 10% (w/w) of an antioxidant.

13. The method of claim 12 , wherein the antioxidant comprises a vitamin E compound.

14. The method of claim 12 , wherein the antioxidant is selected from the group consisting of tocopherol acetate, tocopherol linoleate, tocopherol nicotinate, tocopherol succinate, ascorbyl tocopherol phosphate, dioleyl tocopherol methylsilanol, tocophersolan, tocopherol linoleate/oleate, and combinations thereof.

15. The method of claim 14 , wherein the antioxidant is tocopherol nicotinate.

16. The method of claim 1 , wherein the composition further comprises about 1% to about 10% (w/w) of an insect growth regulator.

17. The method of claim 1 , wherein the composition comprises about 1% to about 5% (w/w) of an insect growth regulator.

18. The method of claim 17 , wherein the insect growth regulator is a juvenile hormone mimic selected from the group consisting of fenoxycarb, hydroprene, kinoprene, methoprene, pyriproxyfen, triprene, and combinations thereof.

19. The method of claim 13 , wherein the insect growth regulator is pyriproxyfen.

20. The method of claim 1 , wherein the composition comprises between about 1% to about 50% (w/w) cyphenothrin.

21. The method of claim 1 , wherein the organic solvent comprises diethylene glycol monoethyl ether.

22. The method of claim 1 , wherein the composition is administered once every four weeks.

23. A method of reducing the incidence of flea allergy dermatitis in a companion animal by reducing blood feeding by ectoparasites on the companion animal by at least 80%, the method comprising: administering a composition comprising up to about 50% (w/w) cyphenothrin, up to about 5% (w/w) insect growth regulator, and about 50% to about 85% (w/w) diethylene glycol monoethyl ether, wherein the composition is administered once every four weeks in a volume sufficient to deliver a dosage of cyphenothrin ranging from about 0.1 mg/kg to about 40 mg/kg of animal weight.

24. A method of reducing the incidence of flea allergy dermatitis in a companion animal by reducing blood feeding by ectoparasites on the companion animal by at least 80%, the method comprising: administering a composition comprising about 20% (w/w) cyphenothrin, about 2% (w/w) pyriproxyfen, and about 78% (w/w) diethylene glycol monoethyl ether, wherein the composition is administered once every four weeks in a volume sufficient to deliver a dosage of cyphenothrin ranging from about 0.1 mg/kg to about 40 mg/kg of animal weight.

25. A method of reducing the incidence of flea allergy dermatitis in a companion animal by reducing blood feeding by ectoparasites on the companion animal by at least 80%, the method comprising: administering a composition comprising about 30% (w/w) cyphenothrin, about 2% (w/w) pyriproxyfen, and about 68% (w/w) diethylene glycol monoethyl ether, wherein the composition is administered once every four weeks in a volume sufficient to deliver a dosage of cyphenothrin ranging from about 0.1 mg/kg to about 40 mg/kg of animal weight.

26. A method of reducing the incidence of flea allergy dermatitis in a dog weighing between 11 and 20 pounds by reducing blood feeding by ectoparasites on the dog by at least 80%, the method comprising:

(a) removing one 4.0 mL tube containing a composition comprising about 30% (w/w) cyphenothrin, about 2% (w/w) pyriproxyfen, and about 68% (w/w) diethylene glycol monoethyl ether from a package;

(b) opening the tube to form an open end of the tube;

(c) placing the open end of the tube onto the dog's skin; and

(d) squeezing the tube to apply the composition to the dog's skin.

27. The method of claim 26 , further comprising disposing of the tube in a trash receptacle after application of the composition to the dog.

28. The method of claim 26 , wherein the open end of the tube is placed on a starting location high on the back of the dog's neck.

29. The method of claim 28 , further comprising squeezing the tube to deposit the composition as a stripe from the starting location to an ending point.

30. The method of claim 29 , wherein the ending point is midway between the dog's neck and tail.

31. The method of claim 26 , further comprising repeating the method once every four weeks.

32. A method of reducing the incidence of flea allergy dermatitis in a dog weighing between 21 and 39 pounds by reducing blood feeding by ectoparasites on the dog by at least 80%, the method comprising:

(a) removing one 3.0 mL tube containing a composition comprising about 30% (w/w) cyphenothrin, about 2% (w/w) pyriproxyfen, and about 68% (w/w) diethylene glycol monoethyl ether from a package;

(b) opening the tube to form an open end of the tube;

(c) placing the open end of the tube onto the dog's skin; and

(d) squeezing the tube to apply the composition to the dog's skin.

33. A method of reducing the incidence of flea allergy dermatitis in a dog weighing between 40 and 60 pounds by reducing blood feeding by ectoparasites on the dog by at least 80%, the method comprising:

(a) removing one 4.5 mL tube containing a composition comprising about 30% (w/w) cyphenothrin, about 2% (w/w) pyriproxyfen, and about 68% (w/w) diethylene glycol monoethyl ether from a package;

(b) opening the tube to form an open end of the tube;

(c) placing the open end of the tube onto the dog's skin; and

(d) squeezing the tube to apply the composition to the dog's skin.

34. A method of reducing the incidence of flea allergy dermatitis in a dog weighing at least 61 pounds by reducing blood feeding by ectoparasites on the dog by at least 80%, the method comprising:

(a) removing one 6.0 mL tube containing a composition comprising about 30% (w/w) cyphenothrin, about 2% (w/w) pyriproxyfen, and about 68% (w/w) diethylene glycol monoethyl ether from a package;

(b) opening the tube to form an open end of the tube;

(c) placing the open end of the tube onto the dog's skin; and

(d) squeezing the tube to apply the composition to the dog's skin.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2024
From: KEYBANK NATIONAL ASSOCIATION
To: PETIQ HOLDINGS, LLC; PETIQ, LLC; SERGEANT’S PET CARE PRODUCTS, LLC; COMMUNITY VETERINARY CLINICS, LLC; FIDOPHARM, INC.; TRURX LLC; VELCERA, LLC
Reel/Frame 069269/0614 →
RELEASE OF SECURITY INTEREST Recorded Oct 29, 2024
From: JEFFERIES FINANCE LLC
To: PETIQ HOLDINGS, LLC; PETIQ, LLC; SERGEANT’S PET CARE PRODUCTS, LLC; COMMUNITY VETERINARY CLINICS, LLC; FIDOPHARM, INC.; TRURX LLC; VELCERA, LLC
Reel/Frame 069052/0290 →
FIRST LIEN PATENT SECURITY AGREEMENT (TL) Recorded Oct 28, 2024
From: PETIQ, INC.; PETIQ, LLC; TRURX LLC; VELCERA, LLC; FIDOPHARM, INC.; SERGEANT’S PET CARE PRODUCTS, LLC
To: ARES CAPITAL CORPORATION, AS COLLATERAL AGENT
Reel/Frame 069272/0659 →
ABL PATENT SECURITY AGREEMENT Recorded Oct 28, 2024
From: PETIQ, INC.; PETIQ, LLC; TRURX LLC; VELCERA, LLC; FIDOPHARM, INC.; SERGEANT’S PET CARE PRODUCTS, LLC
To: KEYBANK NATIONAL ASSOCIATION, AS COLLATERAL AGENT
Reel/Frame 069272/0670 →
RELEASE OF SECURITY INTEREST IN INTELLECTUAL PROPERTY AT R/F 049711/0975 Recorded Apr 14, 2021
From: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
To: SERGEANT'S PET CARE PRODUCTS, INC.
Reel/Frame 055923/0978 →
SECURITY INTEREST Recorded Apr 14, 2021
From: PETIQ HOLDINGS, LLC; PETIQ, LLC; SERGEANT'S PET CARE PRODUCTS, LLC; COMMUNITY VETERINARY CLINICS, LLC; FIDOPHARM, INC.; TRURX LLC; VELCERA, LLC
To: JEFFERIES FINANCE LLC
Reel/Frame 055915/0408 →
ENTITY CONVERSION Recorded Oct 18, 2019
From: SERGEANT'S PET CARE PRODUCTS, INC.
To: SERGEANT'S PET CARE PRODUCTS, LLC
Reel/Frame 050767/0170 →
SECURITY INTEREST Recorded Jul 10, 2019
From: SERGEANT'S PET CARE PRODUCTS, INC.
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 049711/0975 →
CORRECTIVE ASSIGNMENT TO CORRECT INCORRECT STATE IN WHICH ASSIGNEE IS LOCATED PREVIOUSLY RECORDED ON REEL 028384, FRAME 0428. Recorded Sep 30, 2013
From: NOUVEL, LARRY
To: SERGEANT'S PET CARE PRODUCTS, INC.
Reel/Frame 031314/0785 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2012
From: NOUVEL, LARRY
To: SERGEANT'S PET CARE PRODUCTS, INC.
Reel/Frame 028384/0428 →